Exercise Interventions for Prediabetes Fatigue
Trial Summary
What is the purpose of this trial?
Pre-diabetes (Pre-D) is a precursor to type 2 diabetes (T2D) and characterized by increased exercise fatigability of lower limb muscles, that can impede exercise performance. The cause for the increased fatigability in people with Pre-D is not known. Given the profound vascular disease present in people who have had uncontrolled diabetes for several years, we will determine whether dynamic, fatiguing contractions of the lower limb muscles in people with Pre-D are limited by vascular dysfunction at multiple levels along the vascular tree including the artery, arteriole, and/or capillary. This clinical trial involves a novel exercise training regime involving blood flow restriction to the exercising limb will be used as a probe to further understand the vascular mechanisms for increased fatigability in people with Pre-D and T2D. The long-term goal is to better understand what limits exercise and functional performance in people with diabetes to help develop targeted, more effective exercise programs.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are on insulin, hormone replacement drugs, or vasoactive medications.
What data supports the effectiveness of the treatment Blood Flow Restriction Exercise for prediabetes fatigue?
Is blood flow restriction exercise safe for humans?
Blood flow restriction exercise is generally safe for healthy individuals, but it may cause increased blood pressure and other cardiovascular issues, especially in people with existing health conditions like heart disease, diabetes, or high blood pressure. It's important to have a medical screening before starting this type of exercise to ensure safety.678910
How is Blood Flow Restriction Exercise different from other treatments for prediabetes fatigue?
Blood Flow Restriction Exercise is unique because it involves performing low-intensity exercises while restricting blood flow to the muscles, which can enhance muscle strength and endurance with less strain compared to traditional high-intensity workouts. This method may be particularly beneficial for individuals with prediabetes who might struggle with more intense exercise regimens.12111213
Eligibility Criteria
This trial is for adults aged 30-85 with pre-diabetes or type 2 diabetes, characterized by specific HbA1c and blood glucose levels. It's not open to smokers, those with poor glycemic control, severe obesity, untreated hypothyroidism, certain medication users, or individuals with cardiovascular or musculoskeletal conditions that limit exercise.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants perform 8 weeks of dynamic unilateral resistance exercise training with and without blood flow restriction
Follow-up
Participants are monitored for changes in strength, blood flow, muscle oxygenation, and other physiological measures
Treatment Details
Interventions
- Blood Flow Restriction Exercise
- Control Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
Marquette University
Lead Sponsor
University of Michigan
Collaborator
University of Illinois at Chicago
Collaborator
Medical College of Wisconsin
Collaborator